Toll-Like Receptor-4 Modulation for Cancer Immunotherapy

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2014.00328
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Recent Advances on Toll-Like Receptor 4 Modulation: New Therapeutic Perspectives

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2018English

Toll-Like Receptor 4 in Atherosclerosis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2007English

Toll-Like Receptor 4 Deficiency Impairs Motor Coordination

Frontiers in Neuroscience
Neuroscience
2016English

Bacterial Modulation of Human Fetal Membrane Toll-Like Receptor Expression

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2012English

Resistin Inhibits Neuronal Autophagy Through Toll Like Receptor 4

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies

Frontiers in Pharmacology
Pharmacology
2018English

Adjuvant for Vaccine Immunotherapy of Cancer - Focusing on Toll-Like Receptor 2 and 3 Agonists for Safely Enhancing Antitumor Immunity

Cancer Science
Cancer ResearchMedicineOncology
2015English

Association Between Toll-Like Receptor 4 (Thr399Ile and Asp299Gly), Toll-Like Receptor 2 196-174 Deletion Polymorphisms With Cryptosporidiosis

Journal of Biosciences and Medicines
2016English

Toll-Like Receptor-4 and Lipoprotein Accumulation in Macrophages

Trends in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy